University of Miami - Miller School of Medicine is a clinical research site located in Miami, Florida, United States 33125.
Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.
University of Miami - Miller School of Medicine has participated in 16 clinical trials with 2 currently active.
Therapeutic areas: Epidermolysis Bullosa, Junctional, Epidermolysis Bullosa Dystrophica, Multiple Sclerosis, Relapsing-Remitting.
Sponsors: Organogenesis, Mallinckrodt ARD LLC, Hospira, now a wholly owned subsidiary of Pfizer.
Trust Score: 81/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
University of Miami - Miller School of Medicine has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Miami - Miller School of Medicine has 16 clinical trials on record, with 2 currently active. Their work covers Epidermolysis Bullosa, Junctional, Epidermolysis Bullosa Dystrophica, Multiple Sclerosis, Relapsing-Remitting.
Yes — University of Miami - Miller School of Medicine holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.